*ST銀億(000981.SZ):法院裁定批准重整計劃
格隆匯 12 月 15日丨*ST銀億(000981.SZ)公佈,銀億股份第二次債權人會議及出資人組會議於2020年12月11日召開,有財產擔保債權組、普通債權組均表決通過了《銀億股份有限公司重整計劃(草案)》,出資人組也表決通過了《銀億股份有限公司重整計劃(草案)之出資人權益調整方案》。
根據《中華人民共和國企業破產法》(《企業破產法》)第八十六條的規定,公司及管理人於2020年12月11日向寧波中院提交了《關於提請裁定批准重整計劃的報告》,2020年12月15日,管理人收到寧波中院發來的(2020)浙02破4號之一《民事裁定書》,裁定批准銀億股份有限公司重整計劃,並終止銀億股份重整程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.